Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ladybird homeobox 1 (LBX1) is a protein-coding gene encoding a transcription factor that was identified due to its homology to the Drosophila lady bird genes. It is essential for the migration of muscle precursor cells during development, the specification of dorsal muscle identities in the forelimb, and the development of GABAergic interneurons in the dorsal horn of the spinal cord. LBX1’s disruption can lead to congenital and musculoskeletal syndromes, most notably congenital central hypoventilation syndrome and Leri-Weill dyschondrosteosis. The gene is located at chromosome 10q24 and exhibits classic homeobox domain architecture involved in sequence-specific DNA binding and transcriptional regulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ladybird homeobox 1 (LBX1).